The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases has become a critical driver for the at-home testing kits market in Latin America. These chronic conditions require consistent monitoring of health metrics, including blood glucose levels, cholesterol, and blood pressure, to ensure effective management and prevent complications. Traditionally, patients had to visit healthcare facilities frequently for such tests, but the growing demand for convenience has led to a shift toward at-home diagnostic solutions. At-home testing kits allow individuals to monitor their health regularly without leaving their homes, which is especially beneficial for those with limited access to healthcare facilities or in rural areas.
The need for early detection also drives this demand. Chronic diseases often progress gradually, and early identification of abnormal health indicators can make a significant difference in preventing the worsening of conditions. At-home testing kits offer patients the ability to perform regular self-checks, helping them catch warning signs early and seek timely medical intervention. Additionally, the convenience of home-based testing reduces the time, effort, and costs associated with frequent doctor visits, which is an appealing factor for patients managing long-term conditions.
Access Full Report @ https://www.databridgemarketresearch.com/es/reports/latin-america-at-home-testing-kits-market
Data Bridge Market Research analyzes that the Latin America At-Home Testing Kits Market is expected to grow at a CAGR of 4.7% in the forecast period of 2024 to 2031 and is expected to reach USD 755.84 million by 2031 from USD 525.88 million in 2023.
Key Findings of the Study
“Growing Adoption of Self-Testing Kits”
Earlier, people frequently visited hospitals even for basic health concerns. However, with increasing awareness about at-home testing products, this behavior has shifted significantly. Today, many consumers prefer to use self-testing kits at home for basic tests before consulting a doctor. This growing trend offers convenience, as individuals can quickly access their test results with ease. In Latin America, the rising adoption of self-testing kits is a key driver of the At-Home Testing Kits Market, especially in regions with limited healthcare infrastructure. These kits provide an affordable, reliable, and convenient solution for patients to monitor their health, reducing the need for frequent hospital visits. They are particularly beneficial in rural and underserved areas, enabling early detection and management of conditions such as diabetes, COVID-19, and sexually transmitted infections. By decreasing hospital overcrowding and lowering consultation and diagnostic fees, self-testing kits not only improve healthcare access but also help curb hospital expenses, making them a practical solution for both patients and healthcare systems.
The rising adoption of self-testing kits in Latin America is driving the at-home testing kits market by addressing healthcare accessibility issues and significantly cutting down hospital expenses, offering a practical solution for both patients and healthcare systems.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Million, and Pricing in USD
|
|
Segments Covered
|
Test Type (Pregnancy Test, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kits, and Other Test Types), Type (Cassettes, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Other Sample Types), Usage (Disposable and Reusable), Distribution Channel (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies)
|
|
Countries Covered
|
Brazil, Argentina, Rest of LATAM
|
|
Market Players Covered
|
Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), BD (U.S.), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (U.S.), ACON Laboratories, Inc. (U.S.), ARKRAY, Inc. (Japan), B. Braun SE (Germany) , Bionime Corporation (Taiwan), OraSure Technologies Inc. (U.S.), SA Scientific Ltd. (U.S.), and PRIMA Lab SA (Switzerland), among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
Latin America at-home testing kits market is segmented into six notable segments based on basis of test type, type, age, sample type, usage and distribution channels
- On the basis of test type, the market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit and other test types.
In 2024, the glucose tests segment is expected to dominate the market
In 2025, the glucose tests segment is expected to dominate the market with a market share of 51.02% due to the increasing awareness about early detection and the affordability and accessibility of home-based kits.
- On the basis of type, the market is segmented into cassette, strip, midstream, test panel, dip card and other form types
In 2024, the strip segment of the type segment is expected to dominate the market
In 2024, the strip segment is expected to dominate the market with a market share of 52.37% due to their ease of use, low cost, and quick results. This segment is expected to dominate the market.
- On the basis of age, the market is segmented into pediatric, adult, and geriatric. In 2024, the adult segment is expected to dominate the market with a market share of 60.54%
- On the basis of sample type, the market is segmented into urine, blood, saliva, and other sample types. In 2024, the blood segment is expected to dominate the market with a market share of 54.74%
- On the basis of usage, the market is segmented into disposable and reusable. In 2024, the disposable segment is expected to dominate the market with a market share of 67.45%
- On the basis of distribution channel, the market is segmented into retail pharmacies, drug store, supermarket/hypermarket and online pharmacies. In 2024, the retail pharmacies segment is expected to dominate the market with a market share of 51.63%
Major Players
Data Bridge Market Research recognizes the following companies as the major At-Home Testing Kits players in the market that include Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), BD (U.S.), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (U.S.), among others as the major market players of the market.
Market Development
- In July 2024, ACON Laboratories, Inc. announced that it has received emergency use authorization from the U.S. FDA for its Flowflex Plus COVID-19 and Flu A/B Home Test. This test detects SARS-CoV-2, influenza A, and B antigens using self-collected nasal swabs for individuals aged 14 and older or adult-collected samples for those two and older.
This authorization enhances ACON's product line and market presence in home testing, positioning the company to meet rising demand and capture a larger share of the point-of-care testing market.
- In November 2023, ACON Laboratories, Inc. has announced that the U.S. FDA has granted 510(k) marketing clearance for its Flowflex COVID-19 Antigen Home Test. This marks the first FDA 510(k) clearance for an over-the-counter rapid antigen test for SARS-CoV-2.
This milestone positions ACON as a leader in the OTC rapid testing market, enhancing its competitive edge and expanding its product offerings, ultimately driving growth in consumer demand for accessible COVID-19 testing solutions.
- In December 2021, F. Hoffmann-La Roche Ltd announced that they have received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its COVID-19 At-Home Test. This test utilizes an easy-to-use anterior nasal swab that can be self-collected by individuals aged 14 and older, and by adults for children aged 2-13.
This authorization will help the company expand its product offerings in the at-home testing market, enhancing its reputation and sales potential amid ongoing demand for accessible COVID-19 testing solutions.
- In April 2021, Abbott has announced that the BinaxNOW COVID-19 Self Test is now available over-the-counter at CVS Pharmacy, Walgreens, and Walmart, with nationwide availability, making rapid COVID-19 self-testing more accessible to the public.
- In August 2020, Siemens Healthcare GmbH has entered in to an agreement with Varian Medical Systems, Inc. With this acquisition Siemens Healthcare will help in developing advance solutions to treat against cancer and strengthen their position in healthcare industry.
- In July 2020, BD, a leading global medical technology company, has announced that they have completed the acquisition of Straub Medical AG, a privately-held company. With this acquisition the company will add the valuable expertise and experience of Straub Medical AG and will expand their product portfolio.
Regional Analysis
Geographically, the countries covered in the Latin America at-home testing kits market report is Brazil, Argentina, and Rest of LATAM.
As per Data Bridge Market Research analysis:
Mexico is the dominant country in the Latin America at-home testing kits market during the forecast period of 2024 to 2031
Mexico is expected to dominate the market due to its well-established healthcare infrastructure and high adoption rate of advanced technologies, including cloud-based solutions and automation. Supportive government initiatives and significant investments in healthcare IT drive innovation and enhance the efficiency of laboratory operations in the region.
For more detailed information about the Latin America At-Home Testing Kits market report, click here – https://www.databridgemarketresearch.com/es/reports/latin-america-at-home-testing-kits-market
